Seamus Mulligan
Director · Jazz Pharmaceuticals plc
IndividualBuying only
- 2025
- Aug 7, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Seamus Mulligan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $27.78M in JAZZ purchases and sales in the last 12 months
- Robert Iannone - $20.41M in JAZZ purchases and sales in the last 12 months
- Neena M. Patil - $11.50M in JAZZ purchases and sales in the last 12 months
- Patricia Carr - $1.66M in JAZZ purchases and sales in the last 12 months
- Rick E. Winningham - $1.66M in JAZZ purchases and sales in the last 12 months
- Samantha Pearce - $1.63M in JAZZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Seamus Mulligan?
Seamus Mulligan is a corporate insider, tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Seamus Mulligan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Seamus Mulligan been buying or selling stock?
Recorded transactions: 4 open-market purchases ($9.99M) and 0 open-market sales across all tracked filings.
